Abstract
Vaccinology is a growing field in which plant-based vaccines constitute an attractive development trend. This approach consists of the use of plant cells as biofactories of immunoprotective antigens, which can be administered to the matrix of plant biomass by the oral route or parenterally after purification. Rationale of a plant-based oral vaccine relies on the ability of inducing immune response by the gut-associated lymphoid tissues (GALT). Preclinical development stages of this kind of platform comprise the following steps: (1) immunogen design and gene synthesis; (2) expression of the immunogen of interest by means of plant genetic engineering approaches, such as stable or transient transformation by Agrobacterium tumefaciens, biolistics, or using viral-based vectors or chimeric viruses that serve as expression vectors or carriers; and (3) evaluation of the antigenic, immunogenic, and immunoprotective properties. This chapter describes the basic concepts behind this biotechnology approach, which is considered to have the potential to introduce products into the market in the near future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alvarez ML, Pinyerd HL, Crisantes JD, Rigano MM, Pinkhasov J, Walmsley AM, Mason HS, Cardineau GA (2006) Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice. Vaccine 24:2477–2490
Buetow DE, Korban SS (2000) Transgenic plants producing viral and bacterial antigens. AgBiotech Reviews, http://www.agrobiotechnet.com/Reviews.asp?action=display&openMenu=relateditems&ReviewID=708&Year=2000
Curtiss R III, Cardineau GA (1997) Oral immunization by transgenic plants. United States Patent 5,654,184
Daniell H, Kumar S, Dufourmantel N (2005) Breakthrough in chloroplast genetic engineering of agronomically important crops. Trends Biotechnol 23:238–245
Dormitzer PR, Ulmer JB, Rappuoli R (2008) Structure-based antigen design: a strategy for next generation vaccines. Trends Biotechnol 26:659–667
Drake PM, Thangaraj H (2010) Molecular farming, patents and access to medicines. Expert Rev Vaccines 9:811–819
Earley KW, Haag JR, Pontes O, Opper K, Juehne T, Song K, Pikaard CS (2006) Gateway-compatible vectors for plant functional genomics and proteomics. Plant J 45:616–629
Fischer R, Stoger E, Schillberg S, Christou P, Twyman RM (2004) Plant-based production of biopharmaceuticals. Curr Opin Plant Biol 7:152–158
Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM et al (1995) Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496–512
Fraser CM, Rappuoli R (2005) Application of microbial genomic science to advanced therapeutics. Annu Rev Med 56:459–474
Gasteiger G, Kastenmuller W, Ljapoci R, Sutter G, Drexler I (2007) Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines. J Virol 81:11925–11936
Giddings G, Allison G, Brooks D, Carter A (2000) Transgenic plants as factories for biopharmaceuticals. Nat Biotechnol 18:1151–1155
Gleba Y, Marillonnet S, Klimyuk V (2004) Engineering viral expression vectors for plants: the ‘full virus’ and the ‘deconstructed virus’ strategies. Curr Opin Plant Biol 7:182–188
Gleba Y, Klimyuk V, Marillonnet S (2005) Magnifection–a new platform for expressing recombinant vaccines in plants. Vaccine 23:2042–2048
Goldstein DA, Thomas JA (2004) Biopharmaceuticals derived from genetically modified plants. QJM 97:705–716
Gómez E, Zoth SC, Berinstein A (2009) Plant-based vaccines for potential human application: a review. Hum Vaccine 5:738–744
Grandi G, Nagy E (2012) Finding protective bacterial antigens. In: von Gabain A, Christoph K (eds) Development of novel vaccines. Skills, knowledge and translational technologies. Springer, Wien
Gustafsson C, Govindarajan S, Minshull J (2004) Codon bias and heterologous protein expression. Trends Biotechnol 22:346–353
Hefferon KL (2012) Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins. Virology 433:1–6
Hoover DM, Lubkowski J (2002) DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res 30:e43
Horsch RB, Fraley RT, Rogers SG, Sanders PR, Lloyd A (1985) A simple and general method for transferring genes into plants. Science 227:1229–1231
Howard JA (2005) Commercialization of biopharmaceutical and bioindustrial proteins from plants. Crop Sci 45:468–472
Jenner E (1798) An enquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow pox. Sampson Low, London
Jenner E (1801) The origin of the vaccines inoculation. Shury, London
Karimi M, Inzé D, Depicker A (2002) GATEWAY vectors for Agrobacterium-mediated plant transformation. Trends Plant Sci 7:193–195
Korban SS (2002) Trargeting and expression of antigenic proteins in transgenic plants for production of edible oral vaccines. In Vitro Cell Dev Biol Plant 38:231–236
Liljeqvist S, Ståhl S (1999) Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J Biotechnol 73:1–33
Lugade AA, Kalathil S, Heald JL, Thanavala Y (2010) Transgenic plant-based oral vaccines. Immunol Invest 39:468–482
Ma JK-C, Drake PMW, Christou P (2003) Genetic modification: the production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794–805
Magee AM, Kavanagh TA (2002) Plastid genes transcribed by the nucleus-encoded plastid RNA polymerase show increased transcript accumulation in transgenic plants expressing a chloroplast-localized phage T7 RNA polymerase. J Exp Bot 53:2341–2349
Mestecky J, Nguyen H, Czerkinsky C, Kiyono H (2008) Oral immunization: an update. Curr Opin Gastroenterol 24:713–719
Moriel DG, Scarselli M, Serino L, Mora M, Rappuoli R, Masignani V (2008) Genome-based vaccine development: a short cut for the future. Hum Vaccin 4:184–188
Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, Bui HH, Grey H, Sette A (2006) A consensus epitope prediction approach identifies the breadth of murine T(CD8 + )-cell responses to vaccinia virus. Nat Biotechnol 24:817–819
Moutaftsi M, Salek-Ardakani S, Croft M, Peters B, Sidney J, Grey H, Sette A (2009) Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model. Eur J Immunol 39:717–22
Mowat AM, Viney JL (1997) The anatomical basis of intestinal immunity. Immunol Rev 156:145–166
Pathi K, Tula S, Tuteja N (2013) High frequency regeneration via direct somatic embryogenesis and efficient Agrobacterium-mediated genetic transformation of tobacco. Plant Signal Behav 8:e24354
Pelosi A, Shepherd R, Walmsley AM (2012) Delivery of plant-made vaccines and therapeutics. Biotechnol Adv 30:440–448
Penney CA, Thomas DR, Deen SS, Walmsley AM (2011) Plant-made vaccines in support of the millennium development goals. Plant Cell Rep 30:789–798
Rao AQ, Bakhsh A, Kiani S, Shahzad K, Shahid AA, Husnain T, Riazuddin S (2009) The myth of plant transformation. Biotechnol Adv 27:753–763
Rosales-Mendoza S, Soria-Guerra RE, López-Revilla R, Moreno-Fierros L, Alpuche-Solís AG (2008) Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Rep 27:79–84
Rueckert C, Guzmán CA (2012) Vaccines: from empirical development to rational design. PLoS Pathog 8:e1003001
Salyaev RK, Rigano MM, Rekoslavskaya NI (2010) Development of plant-based mucosal vaccines against wide spread infectious diseases. Expert Rev Vaccines 9:937–946
Sette A, Rappuoli R (2010) Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33:530–541
Sharma AK, Sharma MK (2009) Plants as bioreactors: recent developments and emerging opportunities. Biotechnol Adv 27(6):811–832
Slater A, Scott NW, Fowler MR (2008) Plant biotechnology: the genetic manipulation of plants. Oxford University Press, Oxford, 376 p
Soria-Guerra RE, Moreno-Fierros L, Rosales-Mendoza S (2011) Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches. Plant Cell Rep 30:1367–1382
Staats HF, Jackson RJ, Marinaro M, Takahashi I, Kiyono H, McGhee JR (1994) Mucosal immunity to infection with implications for vaccine development. Curr Opin Immunol 6:572–583
Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 4:607–609
Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ (2000) Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182:302–305
Takahashi I, Nochi T, Yuki Y, Kiyono H (2009) New horizon of mucosal immunity and vaccines. Curr Opin Immunol 21:352–358
Thanavala Y, Mahoney M, Pal S, Scott A, Richter L, Natarajan N, Goodwin P, Arntzen CJ, Mason HS (2005) Immunogenicity in humans of an edible vaccine for hepatitis B. Proc Natl Acad Sci U S A 102:3378–3382
Tiwari S, Verma PC, Singh PK, Tuli R (2009) Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv 27:449–467
Walden R, Schell J (1990) Techniques in plant molecular biology—progress and problems. Eur J Biochem 192:563–576
Wycoff KL (2005) Secretory IgA antibodies from plants. Curr Pharm Des 11:2429–2437
Yusibov V, Streatfield SJ, Kushnir N (2011) Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin 7:313–321
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Govea-Alonso, D., Cardineau, G., Rosales-Mendoza, S. (2014). Principles of Plant-Based Vaccines. In: Rosales-Mendoza, S. (eds) Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0850-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0850-9_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0849-3
Online ISBN: 978-1-4939-0850-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)